Tecartus (brexucabtagene autoleucel) for the Treatment of Mantle Cell Lymphoma (MCL)

Tecartus™ is an autologous, anti-CD19 CAR T cell therapy. Credit: Kite, a Gilead Company.



  • Tecartus
  • Tecartus
  • Tecartus